price
SP
NASDAQ · SPRY
ARS Pharmaceuticals, Inc.
Healthcare · Biotechnology
$4.29
Up+$0.01 (+0.12%)
Updated Oct 7, 2026, 1:57 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.1B
- P/E ratio
- -13.85
- Dividend yield
- 0.00%
- 52-week range
- $3.99 – $10.87
- Volume
- 1.62M
- Avg. volume
- 2.29M
Price performance · SPRY
SPRY price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
SPRY closed at $4.29 after 20 trading sessions, down 20.41% for the selected period.
- Last close
- $4.29
- Period change
- -20.41%
- Period low
- $4.07
- Period high
- $5.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $4.13 | $4.395 | $4.03 | $4.29 | 1.62M |
| Oct 2, 2026 | $4.16 | $4.27 | $3.985 | $4.07 | 1.83M |
| Oct 1, 2026 | $4.35 | $4.395 | $4.11 | $4.12 | 1.97M |
| Sep 30, 2026 | $4.43 | $4.45 | $4.24 | $4.31 | 1.3M |
| Sep 29, 2026 | $4.11 | $4.435 | $4.01 | $4.40 | 1.27M |
| Sep 28, 2026 | $4.06 | $4.19 | $4.00 | $4.13 | 949.89K |
| Sep 25, 2026 | $4.18 | $4.18 | $4.02 | $4.08 | 1.04M |
| Sep 24, 2026 | $4.21 | $4.24 | $4.07 | $4.15 | 1.05M |
| Sep 23, 2026 | $4.49 | $4.49 | $4.11 | $4.18 | 1.37M |
| Sep 22, 2026 | $4.40 | $4.57 | $4.36 | $4.48 | 1.27M |
| Sep 21, 2026 | $4.16 | $4.385 | $4.07 | $4.35 | 1.2M |
| Sep 18, 2026 | $4.10 | $4.20 | $4.10 | $4.11 | 1.89M |
| Sep 17, 2026 | $4.26 | $4.30 | $4.12 | $4.15 | 1.87M |
| Sep 16, 2026 | $4.25 | $4.365 | $4.125 | $4.165 | 1.45M |
| Sep 15, 2026 | $4.50 | $4.50 | $4.2202 | $4.25 | 2.78M |
| Sep 14, 2026 | $4.80 | $4.90 | $4.455 | $4.50 | 2.17M |
| Sep 11, 2026 | $5.13 | $5.19 | $4.73 | $4.76 | 2.57M |
| Sep 10, 2026 | $5.20 | $5.22 | $5.02 | $5.06 | 1.09M |
| Sep 9, 2026 | $5.35 | $5.38 | $5.215 | $5.23 | 874.55K |
| Sep 8, 2026 | $5.515 | $5.535 | $5.305 | $5.39 | 1.09M |
Latest SPRY news
The latest Smart Investors Daily articles mentioning SPRY.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…